SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001595585-21-000082
Filing Date
2021-06-11
Accepted
2021-06-11 18:29:53
Documents
3
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162345057774060.html 4  
1 FORM 4 wf-form4_162345057774060.xml 4 7862
2 D. HIRSCH POA 06.10.2021 poa-tcdaxdh_form4.htm EX-24 3683
3 D. HIRSCH POA 06.10.2021 poa-tcdaxdh_form4001.jpg GRAPHIC 204125
  Complete submission text file 0001595585-21-000082.txt   294210
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LONGITUDE CAPITAL PARTNERS, LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Business Address
Hirsch David (Reporting) CIK: 0001619884 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38558 | Film No.: 211012670